These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23645517)

  • 1. Molecular profiling of ADAM12 and ADAM17 genes in human malignant melanoma.
    Cireap N; Narita D
    Pathol Oncol Res; 2013 Oct; 19(4):755-62. PubMed ID: 23645517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of ADAM12 and ADAM17 genes in laser-capture microdissected breast cancers and correlations with clinical and pathological characteristics.
    Narita D; Seclaman E; Ursoniu S; Anghel A
    Acta Histochem; 2012 Feb; 114(2):131-9. PubMed ID: 21501859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADAM12 and ADAM17 gene expression in laser-capture microdissected and non-microdissected breast tumors.
    Narita D; Seclaman E; Ilina R; Cireap N; Ursoniu S; Anghel A
    Pathol Oncol Res; 2011 Jun; 17(2):375-85. PubMed ID: 21240579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular profiling of ADAM12 gene in breast cancers.
    Nariţa D; Anghel A; Seclaman E; Ilina R; Cireap N; Ursoniu S
    Rom J Morphol Embryol; 2010; 51(4):669-76. PubMed ID: 21103624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha, L-selectin, and tumor necrosis factor alpha.
    Le Gall SM; Bobé P; Reiss K; Horiuchi K; Niu XD; Lundell D; Gibb DR; Conrad D; Saftig P; Blobel CP
    Mol Biol Cell; 2009 Mar; 20(6):1785-94. PubMed ID: 19158376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the ectodomain-releasing protease ADAM17 is directly regulated by the osteosarcoma and bone-related transcription factor RUNX2.
    Araya HF; Sepulveda H; Lizama CO; Vega OA; Jerez S; Briceño PF; Thaler R; Riester SM; Antonelli M; Salazar-Onfray F; Rodríguez JP; Moreno RD; Montecino M; Charbonneau M; Dubois CM; Stein GS; van Wijnen AJ; Galindo MA
    J Cell Biochem; 2018 Nov; 119(10):8204-8219. PubMed ID: 29923217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulated expression of ADAM17 in gastrointestinal stromal tumors: coexpression with EGFR and EGFR ligands.
    Nakagawa M; Nabeshima K; Asano S; Hamasaki M; Uesugi N; Tani H; Yamashita Y; Iwasaki H
    Cancer Sci; 2009 Apr; 100(4):654-62. PubMed ID: 19298600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of ADAM (a disintegrin and metalloproteinase) genes between human first trimester villous and extravillous trophoblast cells.
    Takahashi H; Yuge K; Matsubara S; Ohkuchi A; Kuwata T; Usui R; Suzuki M; Takizawa T
    J Nippon Med Sch; 2014; 81(3):122-9. PubMed ID: 24998958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulated expression of ADAM12 is associated with progression of oral squamous cell carcinoma.
    Uehara E; Shiiba M; Shinozuka K; Saito K; Kouzu Y; Koike H; Kasamatsu A; Sakamoto Y; Ogawara K; Uzawa K; Tanzawa H
    Int J Oncol; 2012 May; 40(5):1414-22. PubMed ID: 22267082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A disintegrin and metalloproteinase 12 (ADAM12) localizes to invasive trophoblast, promotes cell invasion and directs column outgrowth in early placental development.
    Aghababaei M; Perdu S; Irvine K; Beristain AG
    Mol Hum Reprod; 2014 Mar; 20(3):235-49. PubMed ID: 24243624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of ADAM10 as a major TNF sheddase in ADAM17-deficient fibroblasts.
    Mezyk-Kopeć R; Bzowska M; Stalińska K; Chełmicki T; Podkalicki M; Jucha J; Kowalczyk K; Mak P; Bereta J
    Cytokine; 2009 Jun; 46(3):309-15. PubMed ID: 19346138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAM10 correlates with uveal melanoma metastasis and promotes in vitro invasion.
    Gangemi R; Amaro A; Gino A; Barisione G; Fabbi M; Pfeffer U; Brizzolara A; Queirolo P; Salvi S; Boccardo S; Gualco M; Spagnolo F; Jager MJ; Mosci C; Rossello A; Ferrini S
    Pigment Cell Melanoma Res; 2014 Nov; 27(6):1138-48. PubMed ID: 25124714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metalloproteinase-disintegrin ADAM12 is associated with a breast tumor-initiating cell phenotype.
    Li H; Duhachek-Muggy S; Dubnicka S; Zolkiewska A
    Breast Cancer Res Treat; 2013 Jun; 139(3):691-703. PubMed ID: 23771733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annexin A2 regulates a disintegrin and metalloproteinase 17-mediated ectodomain shedding of pro-tumor necrosis factor-α in monocytes and colon epithelial cells.
    Tsukamoto H; Tanida S; Ozeki K; Ebi M; Mizoshita T; Shimura T; Mori Y; Kataoka H; Kamiya T; Fukuda S; Higashiyama S; Joh T
    Inflamm Bowel Dis; 2013 Jun; 19(7):1365-73. PubMed ID: 23702712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of a disintegrin and metalloproteinase 10 and 17 in shedding of tumor necrosis factor-alpha.
    Hikita A; Tanaka N; Yamane S; Ikeda Y; Furukawa H; Tohma S; Suzuki R; Tanaka S; Mitomi H; Fukui N
    Biochem Cell Biol; 2009 Aug; 87(4):581-93. PubMed ID: 19767822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescent substrates for the proteinases ADAM17, ADAM10, ADAM8, and ADAM12 useful for high-throughput inhibitor screening.
    Moss ML; Rasmussen FH
    Anal Biochem; 2007 Jul; 366(2):144-8. PubMed ID: 17548045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analysis of a breast cancer-associated mutation in the intracellular domain of the metalloprotease ADAM12.
    Stautz D; Wewer UM; Kveiborg M
    PLoS One; 2012; 7(5):e37628. PubMed ID: 22662180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: the AtheroGene study.
    Morange PE; Tregouet DA; Godefroy T; Saut N; Bickel C; Rupprecht HJ; Lackner K; Barbaux S; Poirier O; Peiretti F; Nalbone G; Juhan-Vague I; Blankenberg S; Tiret L
    J Mol Med (Berl); 2008 Oct; 86(10):1153-61. PubMed ID: 18600307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of ADAM10, ADAM12, ADAM17 AND ADAM28 in colorectal cancer patients.
    Walkiewicz K; Nowakowska-Zajdel E; Strzelczyk J; Dzięgielewska-Gęsiak S; Muc-Wierzgoń M
    J Biol Regul Homeost Agents; 2017; 31(4):929-934. PubMed ID: 29254295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The "A Disintegrin And Metalloproteases" ADAM10 and ADAM17: novel drug targets with therapeutic potential?
    Saftig P; Reiss K
    Eur J Cell Biol; 2011; 90(6-7):527-35. PubMed ID: 21194787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.